Skip to main content
Nut Koonrungsesomboon on Muck Rack

Nut Koonrungsesomboon

As seen in: Nature, Frontiers, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nut

Contact Nut, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Efficacy of pulmonary surfactant with budesonide in infants born at or less than 28 weeks’ gestation: a systematic review and meta-analysis - Scientific Reports

|
By Nanthida Phattraprayoon, Nut Koonrungsesomboon, Mingkwan Na Takuathung
| Nature Verified
Abstract Pulmonary surfactant (PS) is the standard treatment for respiratory distress syndrome in preterm infants. Budesonide, a corticosteroid with anti-inflammatory properties, has been studied for use with PS to potentially improve respiratory outcomes and reduce bronchopulmonary dysplasia (BPD) risk while minimizing systemic steroid exposure. This study aimed to compare the efficacy of PS with budesonide versus PS alone in infants born ≤ 28 weeks’ gestational age (GA).
Open in Who Shared Issue with article?

Network Pharmacology Revealing the Therapeutic Potential of Bioactive Components of Triphala and Their Molecular Mechanisms against Obesity

|
By Ratchanon Inpan, Mingkwan Na Takuathung, Nut Koonrungsesomboon, Chotiwit Sakuludomkan
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis

|
By Yen-Chen Anne Feng, Nancy Hakooz, Nut Koonrungsesomboon
| Frontiers
Kittika Yampayon1, Puree Anantachoti2, Bunchai Chongmelaxme2*† and Varalee Yodsurang1,3*† 1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand 2Social and Administrative Pharmacy Department, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand 3Preclinical Toxicity and Efficacy, Assessment of Medicines and Chemicals Research Unit, Chulalongkorn University, Bangkok, Thailand Objective: Deferasirox...
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)